NCT05180240

Impact of CardiolRx on Myocardial Recovery in Patients With Acute Myocarditis

CompletedPHASE2INTERVENTIONAL

Trial Details

Start: 2022-07-28Est. Completion: 2025-01-31

Enrollment target: 109 participants

Locations

MedStar Heart and Vascular Institute, Washington D.C., District of Columbia, United States
Massachusetts General Hospital site, Boston, Massachusetts, United States
Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, United States
Cleveland Clinic, Cleveland, Ohio, United States
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
Virginia Commonwealth University, Richmond, Virginia, United States
Nupec-Orizonti, Belo Horizonte, Minas Gerais, Brazil
PUC trials, Curitiba, Paraná, Brazil
Complexo Hospitalar de Niterói, Niterói, Rio de Janeiro, Brazil
Hospital Moinhos de Vento, Porto Alegre, Rio Grande do Sul, Brazil
Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, Rio Grande do Sul, Brazil
Hospital Nove de Julho, São Paulo, São Paulo, Brazil
Hospital Felicio Rocho - Fundação Felice Rosso, Belo Horizonte, Brazil
Hospital Angelina Caron, Campina Grande do Sul, Brazil
Hospital São Lucas, Porto Alegre, Brazil
Instituto D´Or de Pesquisa e Ensino, Rio de Janeiro, Brazil

Acute Respiratory Distress SyndromeSepsisCardiovascular Shock

The overall purpose of this protocol is to identify subacute sepsis-associated cardiac disease in pediatric patients wit…

Memphis, United StatesCompleted Mar 21, 2026

ARDS Related to Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 2Acute Refractory Heart Failure Related to SARS-CoV 2

The role of ECMO in the treatment of patients with severe COVID-19 (Acute Respiratory Distress Syndrome (ARDS) and/or ac…

Angers, FranceCompleted May 24, 2022

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.